Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 01, 2015 9:21 PM ET


Company Overview of Akermin, Inc.

Company Overview

Akermin, Inc. develops and commercializes polymer technology. The company’s technology is based on enzyme stabilization and operation to lower costs and create efficiencies in carbon capture systems, biofuel cells, natural gas sweetening, hydrogen production, landfills, and cement kilns. Its technology uses an enzyme, carbonic anhydrase, to accelerate absorption of carbon dioxide. The company was founded in 2003 and is based in St. Louis, Missouri.

1005 North Warson Road

Suite 101

St. Louis, MO 63132

United States

Founded in 2003





Key Executives for Akermin, Inc.

Chief Executive Officer and Director
President, Chief Technology Officer and Director
Co-Founder and Member of Scientific Advisory Board
Director of Finance
Director of Engineering
Compensation as of Fiscal Year 2015.

Akermin, Inc. Key Developments

Akermin Announces the Addition of Three New Members to its Board of Directors

Akermin, Inc. announced the addition of three pivotal members to its board of directors: Mark S. Wrighton Ph.D., Chancellor of Washington University in St Louis; David Danforth, private investor; and Alex Zaks Ph.D., President and Chief Technology Officer at Akermin.

Akermin Signs $7 Million Project in Denmark

Akermin signed a deal to work on a three-year, $7 million demonstration project in Denmark. The project is a major step toward commercializing Akermin's biocatalyst technology, which can remove carbon dioxide from conventional chemical absorption processes. Akermin will receive as much as 30% of the project's budget, or $2.1 million. That money will go toward upgrading Akermin's biocatalyst unit. Akermin would be able to transfer the technology to other segments, including natural gas treatment or ammonia production. The Denmark facility is expected to begin operations in the second quarter of 2015 and last two years. The project demonstration of a biocatalyst to remove CO2 from an industrial gas stream anywhere in the world. The goal of the project, is to demonstrate the benefits of Akermin's technology for biogas upgrading and support Denmark's objective to develop new technology to produce a sustainable but more cost effective bio-methane that will offset combustion of fossil fuels and reduce greenhouse gas emissions to the atmosphere.

Akermin, Inc. Receives $3 Million Cooperative Agreement from the U.S. Department of Energy

Akermin, Inc. announced that it has received a $3 million cooperative agreement to support development of the technology for post-combustion CO2 removal from power plants. The work under this program will build off of Akermin's current field pilot that has now accrued over 2,800 hours of operation, consistently capturing over 80% CO2, with no degradation in performance and no biocatalyst replenishment. This successful demonstration at the National Carbon Capture Center in Wilsonville, AL was also made possible through a cooperative agreement from the Department of Energy's National Energy Technology Laboratory (NETL) in Pittsburgh, PA. The new funding will be used to develop and test Akermin's second generation approach using a simple and cost-effective design enabled by its proprietary Biocatalyst Delivery System. The goal is to demonstrate that the approach can be applied to capture CO2 using less energy, in a process that has lower capital and operating costs. The development target is to capture CO2 from large industrial processes at a cost that will economically enable various CO2 utilization options, including Enhanced Oil Recovery. The work under this cooperative agreement will focus on post-combustion CO2 capture from fossil-fueled power plants. Akermin's technology can also be applied to cost-effectively capture CO2 from the exhaust gas of other industrial processes.

Similar Private Companies By Industry

Company Name Region
JK BioPharma Solutions, Inc. United States
Cook MyoSite Incorporated United States
NuRx Pharmaceuticals, Inc. United States
Martek Biosciences Boulder Corporation United States
Grant Life Sciences, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Akermin, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at